Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...

A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an ...

WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable ...

Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

(MENAFN- Caribbean News Global) GENEVA, Switzerland – WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable lenacapavir as pre ...

Addressing stigma, inequity, and access to HIV innovations remains critical to progress in the global HIV response, says IAS ...